Diagnostic Pathology
ISSN 1746-1596 · BioMed Central · United Kingdom · active 2006–2026
Metrics
“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric. Citation rates differ enormously between fields, so compare within a discipline.
Indexing & access
Access status: gold. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.
Scope
Frequently asked
Is Diagnostic Pathology a predatory journal?
Our screening does not flag Diagnostic Pathology. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in DOAJ, Scopus, Web of Science, PubMed, which is a positive signal.
Is Diagnostic Pathology indexed in Scopus or Web of Science?
Per our venue index, Diagnostic Pathology appears in: DOAJ, Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.
What is Diagnostic Pathology's impact?
Papers in Diagnostic Pathology are cited about 3.1 times each within two years of publication, and Scimago places it in Q1, with an h-index of 78. This is not a Clarivate Journal Impact Factor — we neither compute nor license that metric — and a citation rate is a property of a field as much as of a journal.
Is Diagnostic Pathology open access?
Our index records its access status as "gold". Where this is derived from publisher-level signals rather than works-level data it is a heuristic, so confirm on the journal's own site — particularly if an article processing charge matters to you.
Similar venues
- Modern PathologyQ1 · Elsevier BV
- Current Treatment Options in OncologyQ1 · Springer Science+Business Media
- The American Journal of Surgical PathologyQ1 · Lippincott Williams & Wilkins
- Pathology - Research and Practice— · Elsevier BV
- CancerQ1 · Wiley
- Pathology & Oncology ResearchQ2 · Springer Science+Business Media